As you begin the appropriations process for Fiscal year(FY) 2015, the undersigned Members of Congress ask that you give strong consideration to the burden of diabetes in the United States and provide $20 million for the National Diabetes Prevention Program (NDPP) at the Centers for Disease Control and Prevention (CDC).
Oct 22, 2013
We write to ask for your continued support for the Special Diabetes Program (SDP), which is imporving the lives of 26 million Americans who have diabetes and yielding a real return on the federal investment.
May 29, 2013
As the chairs and vice-chairs of the Congressional Diabetes Caucus, we would like to present the April edition of the Caucus Quarterly Newsletter.
We thought you may be interested in the attached Congressional Research Service (CRS) recently released report on the Federal Activities and Spending for Diabetes Prevention, Research, and Treatment.
To support congressional work on diabetes-related activities CRS has prepared this memorandum providing details of the federal government’s involvement in and spending on diabetes mellitus research, surveillance, prevention and education, and health treatment.
Apr 26, 2012
We write to ask for your continued support of the Special Diabetes Program as we work in a bipartisan manner on its reauthorization. The Special Diabetes Program is demonstrating real returns on the federal investment it has received and is creatiing a brighter future for Americans burdened by diabetes.
Mar 20, 2012
Representatives Reid Ribble and Susan Davis Lead Bipartisan Letter to Appropriators on the National Diabetes Prevention Program
As you complete the appropriations process for Fiscal year 2013, the undersigned Members of Congress ask that you give strong consideration to the burden of diabetes in the United States
Apr 15, 2011
Co-Signers of Attached Letter to FDA Commissioner Hamburg Regarding the Artificial Pancreas
Apr 15, 2011
We are writing to express our strong interest in the development of the artificial pancreas, which is at a critical point in the regulatory process at your agency. Your continued leadership is essential.
Oct 27, 2009
Huntsville AL-Qualitest Pharmaceuticals today issued a voluntary nationwide recall of all Accusure® Insulin Syringes.